Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged, causing a global pandemic called COVID-19. Currently, there is no definitive treatment for this emerging disease. Global efforts resulted in developing multiple platforms of COVID-19 vaccines, but their efficacy in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhangnia, Pooya, Dehrouyeh, Shiva, Safdarian, Amir Reza, Farahani, Soheila Vasheghani, Gorgani, Melika, Rezaei, Nima, Akbarpour, Mahzad, Delbandi, Ali-Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021130/
https://www.ncbi.nlm.nih.gov/pubmed/35483235
http://dx.doi.org/10.1016/j.intimp.2022.108786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021130/
https://www.ncbi.nlm.nih.gov/pubmed/35483235
http://dx.doi.org/10.1016/j.intimp.2022.108786

Ejemplares similares